Spondyloepimetaphyseal dysplasia, Strudwick type

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Spondyloepimetaphyseal dysplasia, Strudwick type
Synonyms	SEMD Strudwick type
Pronounce	N/A
Specialty	Medical genetics
Symptoms	Short stature, skeletal dysplasia, joint pain
Complications	N/A
Onset	Infancy
Duration	Lifelong
Types	N/A
Causes	Mutations in the COL2A1 gene
Risks	Family history of the condition
Diagnosis	Genetic testing, radiographic imaging
Differential diagnosis	Other forms of spondyloepimetaphyseal dysplasia
Prevention	N/A
Treatment	Symptomatic treatment, physical therapy
Medication	N/A
Prognosis	Variable, depending on severity
Frequency	Rare
Deaths	N/A

Spondyloepimetaphyseal Dysplasia, Strudwick Type (SEMD, Strudwick Type) is a rare genetic disorder that affects the development of bones, particularly those in the spine (vertebrae), the ends of long bones (epiphyses), and the bones of the chest. This condition is part of a group of diseases known as skeletal dysplasias, which are characterized by abnormalities in the size and shape of the limbs, trunk, and skull.

Symptoms and Characteristics

Patients with Spondyloepimetaphyseal Dysplasia, Strudwick Type, typically present with a short stature, a short and curved spine (scoliosis and/or kyphosis), and abnormalities in the shape of the pelvis, chest, and long bones. The condition is also associated with problems in the development of the epiphyseal plate, leading to shortening and deformities of the limbs. Other common features include a barrel-shaped chest, a protruding abdomen, and distinctive facial features such as a prominent forehead, a flat nasal bridge, and a small chin.

Genetics

Spondyloepimetaphyseal Dysplasia, Strudwick Type is inherited in an autosomal dominant manner, meaning that only one copy of the altered gene is necessary to cause the disorder. It is caused by mutations in the COL2A1 gene, which provides instructions for making a protein that is essential for the development and maintenance of the cartilage that forms the body's skeletal framework. Mutations in the COL2A1 gene disrupt the normal formation of collagen, leading to the skeletal abnormalities seen in this condition.

Diagnosis

Diagnosis of Spondyloepimetaphyseal Dysplasia, Strudwick Type is primarily based on the clinical presentation and radiographic findings. Genetic testing can confirm the diagnosis by identifying a mutation in the COL2A1 gene. Prenatal diagnosis is possible if there is a known family history of the condition.

Treatment

There is no cure for Spondyloepimetaphyseal Dysplasia, Strudwick Type, and treatment focuses on managing symptoms and improving quality of life. This may include physical therapy, orthopedic interventions such as surgery to correct bone deformities or to manage scoliosis, and other supportive treatments. Growth hormone therapy has been used in some cases to increase stature, although its effectiveness varies.

Prognosis

The prognosis for individuals with Spondyloepimetaphyseal Dysplasia, Strudwick Type varies. While some individuals may have mild symptoms and lead relatively normal lives, others may experience significant physical limitations. Early and ongoing management of the condition is important to address any complications that arise and to improve overall quality of life.